Skip to main content



06-23-2017 | Cardiovascular disorders | News

Global undertreatment of patients with type 2 diabetes and CVD

Less than one-third of patients with type 2 diabetes and cardiovascular disease are receiving optimal care for secondary prevention of cardiovascular events, suggests an analysis of data from the TECOS trial.

05-22-2017 | Prevention | News

Retention key for US national diabetes prevention efforts

Data from the first 4 years of implementation of the US National Diabetes Prevention Program show promising results, with the more engaged patients achieving the best outcomes.

Read the linked commentary from Leonard Bertheau.

04-21-2017 | Prediabetes | News

Metabolic abnormalities associated with cognitive dysfunction

Impaired fasting plasma glucose and insulin resistance are associated with an increased risk for developing cognitive dysfunction among postmenopausal women, results of a Danish study suggest.

Read more


07-05-2017 | Prevention | Editorial | Article

Type 2 diabetes can be prevented in your patients

Editorial Board member Jay Shubrook and his colleague Alegria Cantillep discuss the National Diabetes Prevention Program, how you might find eligible patients, and how you can refer them to the program.

Journal articles and book chapters

04-28-2017 | Retinopathy | Review | Article

Oxidative stress and diabetic retinopathy: development and treatment

This review describes the possible role of oxidative stress in the development of diabetic retinopathy (DR) and proposes some treatment options based on its stages.

Eye 2017. doi:10.1038/eye.2017.64

G D Calderon, O H Juarez, G E Hernandez, S M Punzo, Z D De la Cruz

02-01-2017 | Lifestyle intervention | Review | Article

Workplace interventions to prevent type 2 diabetes mellitus: A narrative review

The authors provide a comprehensive summary of translations of the Diabetes Prevention Program (DPP) in workplaces and offer an insight into its effectiveness in this setting. Interventions not based on the DPP are also discussed.

Hafez D et al. Curr Diab Rep 2017; 17: 9. doi:10.1007/s11892-017-0840-0

01-25-2017 | Lifestyle intervention | Review | Article

Lifestyle and precision diabetes medicine: Will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?

This review discusses the rationale for precision diabetes medicine, specifically as it relates to lifestyle; existing evidence is scrutinized and the barriers germane to research in this field are discussed.

Franks PW & Poveda A. Diabetologia 2017; 60: 784–792. doi:10.1007/s00125-017-4207-5

image credits